These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4222477)

  • 41. A comparative study of fibrinolytic activity in human, rat, rabbit, and dog blood.
    Hedlin AM; Monkhouse FC; Milojevic SM
    Can J Physiol Pharmacol; 1972 Jan; 50(1):11-6. PubMed ID: 4257760
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of thrombin, plasmin and plasminogen activation by amidino compounds.
    Geratz JD
    Thromb Diath Haemorrh; 1970 Jun; 23(3):486-99. PubMed ID: 4247029
    [No Abstract]   [Full Text] [Related]  

  • 43. Protamine sulfate test for fibrin monomers.
    Sanfelippo MJ; Stevens DJ; Koenig RR
    Am J Clin Pathol; 1971 Aug; 56(2):166-73. PubMed ID: 5567722
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of a turbidimetric method to study the kinetics of inhibition of fibrinolysis in diluted blood plasma].
    Sokolovskaia LI; Lezhen TI; Makogonenko EM
    Ukr Biokhim Zh (1978); 1994; 66(5):47-51. PubMed ID: 7538234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CLINICAL STUDIES ON AN ACTIVATOR FREE PORCINE PLASMIN (PLASMIN-NOVO).
    AMRIS CJ; LARSEN V; MOGENSEN B; STORM O
    Sangre (Barc); 1964; 61():12-8. PubMed ID: 14214872
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of fibrinolytic and thromboplastic activity by Trasylol.
    Amris CJ
    Scand J Haematol; 1966; 3(1):19-32. PubMed ID: 4223779
    [No Abstract]   [Full Text] [Related]  

  • 47. [Observations on fibrinolytic and coagulating activities in pre- and postoperative patients].
    Mishima T; Suzuki H; Kobayashi K; Yamada H; Watanabe T
    Nihon Geka Hokan; 1966 Jan; 35(1):158-66. PubMed ID: 5949883
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies on the fibrinolysis in tumor bearing mice. IV. Mechanism of ascites retention with special reference to plasmin activity of tumor cell origin.
    Funahara Y
    Kobe J Med Sci; 1965 Jun; 11(2):79-88. PubMed ID: 4220693
    [No Abstract]   [Full Text] [Related]  

  • 49. Further purification and properties of Hageman factor cofactor.
    Herbert RJ; Ogston D; Douglas AS
    Biochim Biophys Acta; 1972 Jul; 271(2):371-7. PubMed ID: 4340028
    [No Abstract]   [Full Text] [Related]  

  • 50. [Fibrinolysis and plasmin].
    Yamamura Y
    Nihon Ketsueki Gakkai Zasshi; 1965 Jun; 28(3):338-40. PubMed ID: 4221730
    [No Abstract]   [Full Text] [Related]  

  • 51. [The place of fibrinolytic drugs in the treatment of vascular disorders].
    SALMON J
    Rev Med Liege; 1963 May; 18():316-7. PubMed ID: 13991152
    [No Abstract]   [Full Text] [Related]  

  • 52. [Degradation effects of plasmin on blood clotting factors in plasma].
    Suzuki H
    Nihon Ketsueki Gakkai Zasshi; 1967 Nov; 30(6):846-58. PubMed ID: 4232512
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition by aprotinin of tPA-mediated fibrinolysis during orthotopic liver transplantation.
    Hunt BJ; Cottam S; Segal H; Ginsburg R; Potter D
    Lancet; 1990 Aug; 336(8711):381. PubMed ID: 1697398
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of dextran 70 on the action of the primary fibrinolysis inhibitor ("alpha2-plasmin inhibitor").
    Carlin G; Saldeen T
    Thromb Res; 1978 Apr; 12(4):681-6. PubMed ID: 149394
    [No Abstract]   [Full Text] [Related]  

  • 55. Pathophysiology of plasmin system. II. Fibrinolysis and plasmin (activator)--inhibitor ratio.
    MAKI M; NAGASAWA K
    Tohoku J Exp Med; 1963 Jan; 78():363-9. PubMed ID: 13932347
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of plasmin on the blood coagulation system; history of investigations on fibrinolysis].
    NIEWIAROWSKI S
    Postepy Hig Med Dosw; 1959; 13():225-64. PubMed ID: 14427145
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition of plasmin-mediated fibrinolysis by vitamin E.
    Moroz LA; Gilmore NJ
    Nature; 1976 Jan; 259(5540):235-7. PubMed ID: 129706
    [No Abstract]   [Full Text] [Related]  

  • 58. Fibrinolysis and outflow resistance in the eye.
    Pandolfi M
    Am J Ophthalmol; 1967 Dec; 64(6):1141-8. PubMed ID: 4229211
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of the defibrination syndrome and its sequelae].
    Salmon J; Lefebvre P
    Rev Med Liege; 1971 Jan; 26(1):44-6. PubMed ID: 5313317
    [No Abstract]   [Full Text] [Related]  

  • 60. [Determination of the activity of plasmin and antiplasmins].
    Chepcheruk GS
    Lab Delo; 1977; (2):81-3. PubMed ID: 68148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.